EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases

Damijan Knez, Daniel Diez-Iriepa, Mourad Chioua, Andrea Gottinger, Milica Denic, Fabien Chantegreil, Florian Nachon, Xavier Brazzolotto, Anna Skrzypczak-Wiercioch, Anže Meden, Anja Pišlar, Janko Kos und 11 weitere

Acta Pharmaceutica Sinica B · 2023-05 · 13 (5) · 2152-2175

DOI: 10.1016/j.apsb.2023.01.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2023-05. Verfasst von Damijan Knez und 22 weiteren Autor:innen. Beteiligte Einrichtung: University of Ljubljana, Faculty of Pharmacy, Ljubljana 1000, Slovenia. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero dell’Istruzione, dell’Università e della Ricerca, Javna Agencija za Raziskovalno Dejavnost RS, Università degli Studi di Pavia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We describe the development of quinolylnitrones (QNs) as multifunctional ligands inhibiting cholinesterases (ChEs: acetylcholinesterase and butyrylcholinesterase-hBChE) and monoamine oxidases (hMAO-A/B) for the therapy of neurodegenerative diseases. We identified QN 19, a simple, low molecular weight nitrone, that is readily synthesized from commercially available 8-hydroxyquinoline-2-carbaldehyde. Quinolylnitrone 19 has no typical pharmacophoric element to suggest ChE or MAO inhibition, yet unexpectedly showed potent inhibition of hBChE (IC50 = 1.06 ± 0.31 nmol/L) and hMAO-B (IC50 = 4.46 ± 0.18 μmol/L). The crystal structures of 19 with hBChE and hMAO-B provided the structural basis for potent binding, which was further studied by enzyme kinetics. Compound 19 acted as a free radical scavenger and biometal chelator, crossed the blood-brain barrier, was not cytotoxic, and showed neuroprotective properties in a 6-hydroxydopamine cell model of Parkinson's disease. In addition, in vivo studies showed the anti-amnesic effect of 19 in the scopolamine-induced mouse model of AD without adverse effects on motoric function and coordination. Importantly, chronic treatment of double transgenic APPswe-PS1δE9 mice with 19 reduced amyloid plaque load in the hippocampus and cortex of female mice, underscoring the disease-modifying effect of QN 19.

Schlagwörter

Stichwörter der Autor:innen

6-Hydroxydopamine modelAlzheimer's diseaseButyrylcholinesteraseMonoamine oxidase BMultifunctional ligandsNovel object recognitionPassive avoidance taskQuinolylnitrone

Autor:innen und Institutionen

  • University of Ljubljana, Faculty of Pharmacy, Ljubljana 1000, Slovenia.
  • Laboratory of Medicinal Chemistry (Institute of Organic Chemistry, CSIC); Madrid 28006, Spain.
  • Departamento de Química Orgánicay Química Inorgánica, Alcalá de Henares, Madrid 28871, Spain.
  • Department of Biology and Biotechnology, University of Pavia, Pavia 27100, Italy.
  • Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale des Armées, Paris 91220, France.
  • Department of Animal Anatomy and Preclinical Sciences, University Centre of Veterinary Medicine JU-UA, University of Agriculture in Krakow, Krakow 30-059, Poland.

Förderung

  • Ministero dell’Istruzione, dell’Università e della Ricerca
  • Javna Agencija za Raziskovalno Dejavnost RS
  • Università degli Studi di Pavia
  • Universidad Camilo José Cela
  • Ministère des Armées
  • Ministerio de Economía y Competitividad
  • Ministerio de Ciencia, Innovación y Universidades

Zitieren

APA

Knez, D., Diez-Iriepa, D., Chioua, M., Gottinger, A., Denic, M., Chantegreil, F., Nachon, F., Brazzolotto, X., Skrzypczak-Wiercioch, A., Meden, A., Pišlar, A., Kos, J., Žakelj, S., Stojan, J., Sałat, K., Serrano, J., Fernández, A. P., Sánchez-García, A., Martínez-Murillo, R., …, & Marco-Contelles, J. (2023). 8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases. Acta Pharmaceutica Sinica B, 13(5), 2152-2175. https://doi.org/10.1016/j.apsb.2023.01.013

Vancouver

Knez D, Diez-Iriepa D, Chioua M, Gottinger A, Denic M, Chantegreil F, et al. 8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases. Acta Pharmaceutica Sinica B. 2023;13(5):2152-2175. doi:10.1016/j.apsb.2023.01.013

BibTeX
@article{Knez2023,
  author = {Knez, Damijan and Diez-Iriepa, Daniel and Chioua, Mourad and Gottinger, Andrea and Denic, Milica and Chantegreil, Fabien and Nachon, Florian and Brazzolotto, Xavier and Skrzypczak-Wiercioch, Anna and Meden, Anže and Pišlar, Anja and Kos, Janko and Žakelj, Simon and Stojan, Jure and Sałat, Kinga and Serrano, Julia and Fernández, Ana Patricia and Sánchez-García, Aitana and Martínez-Murillo, Ricardo and Binda, Claudia and López-Muñoz, Francisco and Gobec, Stanislav and Marco-Contelles, José},
  title = {8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2023},
  volume = {13},
  number = {5},
  pages = {2152--2175},
  doi = {10.1016/j.apsb.2023.01.013}
}
Kostenlos starten →